Spine device company Alphatec has relocated to a 120,000-square-foot headquarters in Carlsbad, Calif.

Healthcare technology company Royal Philips has introduced its ClarifEye augmented reality system for minimally invasive spine surgery.

Medtronic and Stryker were named on Fortune's "2021 World's Most Admired Companies" list.

NuVasive, a spine technology company, added Siddhartha Kadia, PhD, to its board of directors effective Feb. 1.

Stryker's spine business was steadier in 2020 than other lines during the pandemic.

Spine device company Surgalign Holdings has priced an underwritten public offering of 25 million  shares of its common stock at $1.50 per share, before underwriting discounts and commissions.

Seven notes from device company notes in the past week, including full-year financial reports from Johnson & Johnson and Stryker.

Orthopedic implant manufacturer Exactech plans to accelerate growth initiatives with three new appointees to its board of directors:

A 10-year-old Amur tiger at Brookfield (Ill.) Zoo underwent a hip replacement surgery at the zoo Jan. 27, News BHT reported Jan. 28.

Stryker's 2020 net sales dropped 3.6 percent, largely due to the COVID-19 pandemic.

Medtronic released its "2020 Global Inclusion, Diversity and Equity Report" which outlines the company's actions for developing and retaining diverse talent.

During Johnson & Johnson's fourth-quarter earnings call, CEO Alex Gorsky projected elective surgical volumes to be most affected in the first quarter, but hopes improved vaccine distribution will lead to more "normalized levels" toward the end of the year, according to The Motley Fool.

The FDA has granted clearance for the Trident SI joint screw system, developed by surgeons from Burnsville, Minn.-based Inspired Spine, according to a Jan. 26 news release.

Chicago-based Granite Creek Capital Partners has invested in implant manufacturer Life Spine.

Here's how Medtronic, Stryker and Johnson & Johnson's shares have fluctuated over the last five days.

Johnson & Johnson's orthopedics sales dropped 12.2 percent year over year in 2020 to $7.7 billion. Sales declined 10.2 percent in the U.S. and 15.2 percent worldwide.

The orthopedic implant market has growth in store and is expected to hit $8.97 billion by 2025, according to a January report from Fior Markets.

From one acquisition in the foot and ankle space to two new product launches, here are the latest device company notes:

Orthopedic device company Sacrix launched the third iteration of SacroFuse, a threaded compression device designed for immediate stabilization of the sacroiliac joint.

Here are three devices that were launched in December: